What's interesting about OWCP is that there really isn't

New Post Public Reply Private Reply Replies (0) Message Board
joey68
What's interesting about OWCP is that there really isn't much holding it down. Could we see .30 cents tomorrow? Its possible.

Who would have thought we could reach .19 today?

Speaking with some acquaintances of mine, they suggested OWCP could be at $30 next year. I think that's high, but for my estimate - taking into consideration the share count, OS, management, the fact that a company already tried to buy OWCP's patents.. its possible we could see $15 second quarter 2017.

The reason I say this is because as of this post we are almost 1/4th the way to one dollar. Fourteen more dollars isn't that difficult to reach, especially in this sector.

Not investment advice

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fresha Teams with Klarna: Shaking Up Beauty Payments

Updated Category News Views 54

New Flexibility at the Beauty Checkout Hey, if you've ever paced back and forth considering signing up for that luxury self-care spree, well, Fresha’s latest move might just tip the scales. The beauty and wellness booking giant has partnered with Klarna, diving headfirst into the Buy Now, Pay Later (BNPL) craze. It's about time, right? Everyone loves a good spa session,...

Continue Reading
Thunes, UnionPay Revamp China Payments with $10K Daily

Updated Category News Views 140

Unveiling a New Era for Cross-Border Payments Thunes is shaking things up, unleashing a fresh wave of possibilities for moving money into China's mainland. In a strategic twist, Thunes has teamed up with UnionPay International, aiming to transform the cross-border payment experience. With a potent combo of bank-grade security and hefty daily transaction limits, this...

Continue Reading
Orthocell's Remplir™ Hits Record U.S. Sales in October

Updated Category News Views 176

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Continue Reading
RD Technologies Ramps Up Cross-Border Payments

Updated Category News Views 148

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Continue Reading
Clarivate Integrates Trademark Data with Microsoft AI

Updated Category News Views 0

You know, the market's all abuzz with AI this, AI that. But today, we're getting a glimpse at something that isn't just hyped-up vaporware; it's actually useful. Clarivate Plc (NYSE:CLVT), which has carved a niche in transformative intelligence, is teaming up with Microsoft to slide their CompuMark trademark data into Microsoft Copilot via something they call IPOne. It's...

Continue Reading
DriveNets' Big Role at FYUZ 26: AI Fabrics Spotlighted

Updated Category News Views 0

Networking Titans Gather at FYUZ 26 Alright, folks, mark the first week of November as a field day for telecom and AI networking enthusiasts. DriveNets, a seasoned player in large-scale networking, is joining forces with some of the industry's giants—AT&T, KDDI, and Broadcom—at the Telecom Infra Project's flagship event, FYUZ 26, unfolding at The Westin Seattle. From...

Continue Reading
Sirolimus-Coated Balloon Shows Promise in TRANSFORM II

Updated Category News Views 63

Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...

Continue Reading
E-commerce Player Temu Protects GIs in New Partnership

Updated Category News Views 54

Temu Takes Action on Geographical Indications You ever get the feeling some companies actually give a damn about what they’re selling? Well, Temu's making moves that seem to argue just that. By stepping into the fold with oriGIn, the global network protecting Geographical Indications (GIs), Temu is staking its claim on protecting authenticity in the vast e-commerce...

Continue Reading
Potatoes vs. Candy: Halloween's Spuddy Surprise

Updated Category News Views 118

When Halloween rolls around, you expect rabid kids clamoring for candy corn and chocolate bars. But this year, Idaho threw a spud into the sweets machine. Idaho's Potatoes Steal the Show In an unexpected twist, the Idaho Potato Commission ran a zany experiment on Halloween: kids had to choose between their beloved Halloween candy and a genuine Idaho potato. Imagine the...

Continue Reading
ENGWE Unleashes Massive Black Friday E-Bike Discounts

Updated Category News Views 65

ENGWE Powers Up the 2026 Black Friday Storm If you’ve ever been on the hunt for a reliable e-bike, ENGWE is making a racket that’ll be impossible to ignore this Black Friday. Starting November 2nd and running up to December 3rd, they’re throwing down the gauntlet with some jaw-dropping deals across their line-up. Now, why should you care? For starters, they’ve...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Pickleball Warmer Designed for Enthusiasts

Updated Category News Views 118

Revolutionizing Pickleball Play in Cold Weather Inventors around the country are constantly looking for ways to improve athletic experiences. One recent innovation is the PICKLE BALL WARMER, a product that aims to enhance the game of pickleball. Pickleball players know how important it is to have equipment that works perfectly, especially when temperatures drop. With this...

Continue Reading
UnitedHealth Reports Earnings Surprise and Revenue Challenge

Updated Category News Views 216

UnitedHealth's Fourth Quarter Earnings Analysis Recently, UnitedHealth (NYSE: UNH) delivered its fourth-quarter earnings report, revealing an EPS of $6.81, surpassing the analyst expectation of $6.74 by $0.07. However, on the revenue front, the company reported $100.8 billion, slightly lower than the anticipated $101.61 billion. This mixed result has analysts abuzz...

Continue Reading
Insightful Earnings Preview for Ramaco Resources Unveiled

Updated Category News Views 213

Preparing for Earnings: Ramaco Resources' Insights Ramaco Resources (NASDAQ: METC) is gearing up for its upcoming quarterly earnings announcement. Investors are advised to stay tuned for key insights and takeaways from the release. This earnings season holds particular significance for the company, and there are several factors to consider ahead of the report. Analyst...

Continue Reading
Hormel Foods Celebrates New Scholarship Recipients for 2024

Updated Category News Views 200

Hormel Foods Honors 2024 Scholarship Winners Hormel Foods Corporation, a distinguished player in the global food industry, takes pride in announcing the latest class of Hormel Heroes Scholarship recipients. This initiative spotlights the achievements of two exceptional students, both with military backgrounds, who are honored with $10,000 scholarships. Empowering Futures...

Continue Reading
Orthopedic Biomaterials Market Expected to Reach $51.5 Billion

Updated Category News Views 103

Growth of the Global Orthopedic Biomaterials Market The Global Orthopedic Biomaterials Market is set to witness significant growth, with projections indicating an increase from USD 19.50 billion in 2023 to USD 51.50 billion by 2033. This remarkable growth is expected to occur at a compound annual growth rate (CAGR) of 10.20% throughout the forecast period. Understanding...

Continue Reading